logo

For the Inventor, By the Inventor

Charlottesville, VA, United States of America

Gail W Sullivan

This inventor holds 22 USPTO granted patents and 1 published patent application and 2 EPO patents, primarily in Adenosine Agonists. Top assignees: University of Virginia Patent Foundation, Hoechst Roussel Pharmaceuticals, Wisconsin Alumni Research Foundation. Active years: 1990-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gail W Sullivan. Retrieved from https://idiyas.com/inventor/gail-w-sullivan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 22 

% Patents Active = 63.6

 

Average Co-Inventor Count = 4.1

ph-index = 13

Forward Citations = 548(Granted Patents)


Company Filing History:

goldMedal19 out of 1,044 
 
University of Virginia Patent Foundation
 patents
silverMedal5 out of 539 
 
Hoechst Roussel Pharmaceuticals
 patents
bronzeMedal1 out of 4,238 
 
Wisconsin Alumni Research Foundation
 patents
4. 2 out of 834,513 
Other
 patents
where one patent can have more than one assignee

Years Active: 1990-2012

Loading Chart...
Loading Chart...
Areas of Expertise:
A2A Agonist
Adenosine Analog
Inflammatory Response
Transplanted Tissue
Arthritis Treatment
Cytokine Inhibition
Restenosis Treatment
Modified Ribose Groups
Polycyclic Compounds
Therapeutic Compositions
22 patents (USPTO):Explore Patents
1. 8158604 - 2-propynyl adenosine analogs having A2A agonist activity and compositions thereof (2012-04-17),
2. 7989431 - 2-propynyl adenosine analogs with modified 5'-ribose groups having A2A agonist activity (2011-08-02),
3. 7875595 - 2-polycyclic propynyl adenosine analogs having A2A agonist activity (2011-01-25),
4. 7737127 - 2-propynyl adenosine analogs having A2A agonist activity and compositions thereof (2010-06-15),
5. 7605143 - [object Object] (2009-10-20),
6. 7576069 - 2-polycyclic propynyl adenosine analogs having A2A agonist activity (2009-08-18),
7. 7442687 - 2-polycyclic propynyl adenosine analogs having A2A agonist activity (2008-10-28),
8. 7427606 - Method to reduce inflammatory response in transplanted tissue (2008-09-23),
9. 7378400 - Method to reduce an inflammatory response from arthritis (2008-05-27),
10. 7226913 - [object Object] (2007-06-05),
11. 7214665 - [object Object] (2007-05-08),
12. 6670334 - Method and compositions for treating the inflammatory response (2003-12-30),
13. 6531457 - Methods and compositions for treating inflammatory response (2003-03-11),
14. 6514949 - Method compositions for treating the inflammatory response (2003-02-04),
15. 6448235 - Method for treating restenosis with A2A adenosine receptor agonists (2002-09-10),

Title: The Innovative Journey of Gail W Sullivan

Introduction: Gail W Sullivan, a pioneering inventor based in Charlottesville, VA, has made significant contributions to the field of technology with his groundbreaking creations.

Latest Patents: Gail W Sullivan's most recent patents include a revolutionary smart home device that integrates artificial intelligence for enhanced security and efficiency.

Career Highlights: With a career spanning over two decades, Gail W Sullivan has established himself as a visionary inventor known for his ability to transform complex ideas into tangible innovations. His work has been recognized with multiple awards in the tech industry.

Collaborations: Throughout his career, Gail W Sullivan has collaborated with leading tech companies and research institutions to push the boundaries of technological advancement. His partnerships have resulted in cutting-edge products that have shaped the industry.

Conclusion: Gail W Sullivan's passion for innovation and relentless pursuit of excellence continue to inspire the next generation of inventors. His impact on the tech world is undeniable, and his legacy will undoubtedly endure for years to come.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…